ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Benefit One Inc
•19 Nov 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Benefit One, Japan Best Rescue System, IJTT, Ohizumi, VNET

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
672 Views
Share
bullish•Celltrion Inc
•15 Nov 2023 01:12

Progress of Merger Between Celltrion Inc and Celltrion Healthcare & Appraisal Rights Issue

On 14 November, Celltrion Inc announced the total amount of stock purchase rights exercised in the merger of Celltrion Inc and Celltrion Healthcare...

Logo
1.3k Views
Share
•13 Nov 2023 01:06

Merger Arb Mondays (13 Nov) - Benesse, JSR, IJTT, Shidax, Cybernet, CMIC, IRC, Hollysys, Healius

This week, the highest gross spreads are 111 (59.5%), Eoflow (38.2%), Benesse (36.3%), Hollysys (19.2%), IRC (19.2%), IJTT (16.0%), Healius...

Logo
735 Views
Share
bullish•Eoflow
•12 Nov 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: CMIC, IRC, Allkem, Benesse, Southern Cross, EOFlow, Shidax

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
660 Views
Share
•06 Nov 2023 01:11

Merger Arb Mondays (06 Nov) - Haitong Intl, NWS, Poly Culture, Eoflow, Origin, Azure, Tietto

This week, the highest gross spreads are 111 (57.1%), Eoflow (38.2%), Hollysys (21.4%), Origin Energy (12.7%), JSR (7.8%), Orecorp (9.9%), Lithium...

Logo
669 Views
Share
x